Showing results (1531-1540 of 1,622) with videos related to

Sort By:
Pageof 163
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Zeitschrift Fur Rheumatologie|August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2015
Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinomaRaphaël Maréchal, Jean-Baptiste Bachet, Annabelle Calomme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 StudyPhilip A Philip, Vaibhav Sahai, Nathan Bahary, et al.
Nature Communications|June 13, 2023
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinomaCharlie Saillard, Flore Delecourt, Benoit Schmauch, et al.
Blood Advances|July 22, 2026
Proteomic and proteogenomic identification of targetable T-cell antigens in multiple myelomaGabriela Zuleger, Niklas de Andrade Krätzig, Piero Giansanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2024
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinomaN Fraunhoffer, P Hammel, T Conroy, et al.
BMC Cancer|July 29, 2023
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82)Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 27, 2026
Validity of Bioelectrical Impedance Analysis for the Assessment of Body Composition in Patients With Systemic SclerosisLucas Denardi Dória, Rafaela Cavalheiro do Espírito Santo, Vanessa Hax, et al.
Pageof 163